Αποτελέσματα Αναζήτησης
Download Medicare Reimbursement Guide. If you have questions related to Cardiolite ® reimbursement, please call (800) 362-2668 (Option 3) or email reimbursement@lantheus.com. Lantheus cannot guarantee coverage or payment for products or procedures.
- Two Day Stress/Rest
Two Day Stress/Rest - Reimbursement - Cardiolite
- Risk Stratification
§The indications for Cardiolite ® are not specific to...
- Imaging Protocols
Imaging Protocols. Suggested Cardiolite ® One-Day...
- Prescribing Information
Prescribing Information - Reimbursement - Cardiolite
- Perfusion and Function
Myocardial Perfusion and Function assessed by a Gated...
- Patients
Patients - Reimbursement - Cardiolite
- Two Day Stress/Rest
CARDIOLITE® is a myocardial perfusion agent indicated for: detecting coronary artery disease by localizing myocardial ischemia (reversible defects) and infarction (non-reversible defects) evaluating myocardial function and developing information for use in patient management decisions.
Cardiolite ® evaluation of myocardial ischemia can be accomplished with rest and cardiovascular stress techniques (e.g. exercise or pharmacologic stress in accordance with the pharmacologic stress agent’s labeling).
29 Ιαν 2010 · Physician billed A9500 with 1-unit. The 1-unit was paid, but we should have billed 2-units. How should I bill for 2nd unit (same day of service) without...
Most Cardiolite Stress Tests take approximately three and a half (3 ½) hours and can be completed in one day. Your test may be scheduled as a two day protocol, which will require you to come in two consecutive days.
A Cardiolite treadmill stress test is an exercise test that is helpful in detecting the presence of coronary artery disease. Coronary artery disease occurs when the heart’s vessels become partially blocked or narrowed by the build-up of fatty materials preventing the heart from receiving the blood it needs to function properly.
CARDIOLITE® is a myocardial perfusion agent indicated for: detecting coronary artery disease by localizing myocardial ischemia (reversible defects) and infarction (non-reversible defects) evaluating myocardial function and developing information for use in patient management decisions.
